Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
Completed
Conditions studied: Tobacco Dependence
In brief
The primary purpose of this investigation is to determine the predictive value of task persistence as measured by a mirror tracing task. A secondary purpose is to evaluate differences in task persistence in smokers with or without schizophrenia. It is hypothesized that task persistence in smokers in both diagnostic categories (schizophrenia and no schizophrenia) will predict tobacco dependence treatment outcome at one and six months. It is also hypothesized that smokers with schizophrenia will show lower levels of task persistence after controlling for other motor skills than smokers without schizophrenia.
Key facts
- Study ID
- NCT00501007
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 203
- Starts
- 2005-02-01
- Expected to finish
- 2013-01-01
- Last updated by the study team
- 2017-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Current smokers must be over the age of 18,
- Must fit into the diagnostic groups schizophrenia / schizoaffective disorder; or the non-schizophrenia group.
- Must smoke at least 10 cigarettes per day
- Must be capable of giving informed consent as measured by Folstein Mini Mental Status Exam of at least 22.
You may not qualify if…
- Those unable to give informed consent.
- Psychotic disorders other than schizophrenia
Where it is running
- UMDNJ Tobacco Dependence Clinic — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.